Journal article icon

Journal article

How to manage the infectious risk under anti-TNF in inflammatory bowel disease.

Abstract:

The advent of biological therapy has had a significant impact on the management of patients with inflammatory bowel disease. Nevertheless, anti-TNF-alpha agents are still used with caution, driven by concerns about the risk of infection. Stringent post-marketing surveillance programmes and registries have allowed early recognition of problems, highlighting an increased risk of infectious complications. Although the focus is on biological drugs, other immunomodulators have been less well scrut...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2174/138945010790310009

Authors


Journal:
Current drug targets
Volume:
11
Issue:
2
Pages:
198-218
Publication date:
2010-02-05
DOI:
EISSN:
1873-5592
ISSN:
1389-4501
URN:
uuid:d1d7aaf1-2779-4741-95e2-84e69004003f
Source identifiers:
256348
Local pid:
pubs:256348

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP